Selected research
Industry Research
Biobanking LIMS Software Industry Research Report 2026
Market perspective
The global Biobanking LIMS Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Biobanking LIMS Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Biobanking LIMS Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Biobanking LIMS Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Biobanking LIMS Software include Cell&Co BioServices, RUCDR LIMS, Csols, Agilent Technologies, CloudLIMS, LabCollector, OpenSpecimen, BSI Systems and TDBioBank, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Biobanking LIMS Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biobanking LIMS Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biobanking LIMS Software Market by Company
Cell&Co BioServices
RUCDR LIMS
Csols
Agilent Technologies
CloudLIMS
LabCollector
OpenSpecimen
BSI Systems
TDBioBank
Autoscribe
LabVantage
Thermo Fisher Scientific
Ocimum Biosolutions
LabKey
Azenta US
Modul-Bio
LIMSABC
Biobanking LIMS Software Segment by Type
Cloud Based
On-Premise
Biobanking LIMS Software Segment by Application
Regenerative Medicine
Life Science
Clinical Research
Biobanking LIMS Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biobanking LIMS Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biobanking LIMS Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biobanking LIMS Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biobanking LIMS Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud Based
- On-Premise
Applications
- Regenerative Medicine
- Life Science
- Clinical Research
Companies covered
- Cell&Co BioServices
- RUCDR LIMS
- Csols
- Agilent Technologies
- CloudLIMS
- LabCollector
- OpenSpecimen
- BSI Systems
- TDBioBank
- Autoscribe
- LabVantage
- Thermo Fisher Scientific
- Ocimum Biosolutions
- LabKey
- Azenta US
- Modul-Bio
- LIMSABC
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biobanking LIMS Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cloud Based
- 2.2.3 On-Premise
- 2.3 Biobanking LIMS Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Regenerative Medicine
- 2.3.3 Life Science
- 2.3.4 Clinical Research
- 2.4 Assumptions and Limitations
3 Biobanking LIMS Software Breakdown Data by Type
- 3.1 Global Biobanking LIMS Software Historic Market Size by Type (2021-2026)
- 3.2 Global Biobanking LIMS Software Forecasted Market Size by Type (2027-2032)
4 Biobanking LIMS Software Breakdown Data by Application
- 4.1 Global Biobanking LIMS Software Historic Market Size by Application (2021-2026)
- 4.2 Global Biobanking LIMS Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biobanking LIMS Software Market Perspective (2021-2032)
- 5.2 Global Biobanking LIMS Software Growth Trends by Region
- 5.2.1 Global Biobanking LIMS Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biobanking LIMS Software Historic Market Size by Region (2021-2026)
- 5.2.3 Biobanking LIMS Software Forecasted Market Size by Region (2027-2032)
- 5.3 Biobanking LIMS Software Market Dynamics
- 5.3.1 Biobanking LIMS Software Industry Trends
- 5.3.2 Biobanking LIMS Software Market Drivers
- 5.3.3 Biobanking LIMS Software Market Challenges
- 5.3.4 Biobanking LIMS Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biobanking LIMS Software Players by Revenue
- 6.1.1 Global Top Biobanking LIMS Software Players by Revenue (2021-2026)
- 6.1.2 Global Biobanking LIMS Software Revenue Market Share by Players (2021-2026)
- 6.2 Global Biobanking LIMS Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biobanking LIMS Software Head Office and Area Served
- 6.4 Global Biobanking LIMS Software Players, Product Type & Application
- 6.5 Global Biobanking LIMS Software Manufacturers Established Date
- 6.6 Global Biobanking LIMS Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biobanking LIMS Software Market Size (2021-2032)
- 7.2 North America Biobanking LIMS Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biobanking LIMS Software Market Size by Country (2021-2026)
- 7.4 North America Biobanking LIMS Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biobanking LIMS Software Market Size (2021-2032)
- 8.2 Europe Biobanking LIMS Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biobanking LIMS Software Market Size by Country (2021-2026)
- 8.4 Europe Biobanking LIMS Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biobanking LIMS Software Market Size (2021-2032)
- 9.2 Asia-Pacific Biobanking LIMS Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biobanking LIMS Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biobanking LIMS Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biobanking LIMS Software Market Size (2021-2032)
- 10.2 South America Biobanking LIMS Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biobanking LIMS Software Market Size by Country (2021-2026)
- 10.4 South America Biobanking LIMS Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biobanking LIMS Software Market Size (2021-2032)
- 11.2 Middle East & Africa Biobanking LIMS Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biobanking LIMS Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biobanking LIMS Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Cell&Co BioServices
- 12.1.1 Cell&Co BioServices Company Information
- 12.1.2 Cell&Co BioServices Business Overview
- 12.1.3 Cell&Co BioServices Revenue in Biobanking LIMS Software Business (2021-2026)
- 12.1.4 Cell&Co BioServices Biobanking LIMS Software Product Portfolio
- 12.1.5 Cell&Co BioServices Recent Developments
- 12.2 RUCDR LIMS
- 12.2.1 RUCDR LIMS Company Information
- 12.2.2 RUCDR LIMS Business Overview
- 12.2.3 RUCDR LIMS Revenue in Biobanking LIMS Software Business (2021-2026)
- 12.2.4 RUCDR LIMS Biobanking LIMS Software Product Portfolio
- 12.2.5 RUCDR LIMS Recent Developments
- 12.3 Csols
- 12.3.1 Csols Company Information
- 12.3.2 Csols Business Overview
- 12.3.3 Csols Revenue in Biobanking LIMS Software Business (2021-2026)
- 12.3.4 Csols Biobanking LIMS Software Product Portfolio
- 12.3.5 Csols Recent Developments
- 12.4 Agilent Technologies
- 12.4.1 Agilent Technologies Company Information
- 12.4.2 Agilent Technologies Business Overview
- 12.4.3 Agilent Technologies Revenue in Biobanking LIMS Software Business (2021-2026)
- 12.4.4 Agilent Technologies Biobanking LIMS Software Product Portfolio
- 12.4.5 Agilent Technologies Recent Developments
- 12.5 CloudLIMS
- 12.5.1 CloudLIMS Company Information
- 12.5.2 CloudLIMS Business Overview
- 12.5.3 CloudLIMS Revenue in Biobanking LIMS Software Business (2021-2026)
- 12.5.4 CloudLIMS Biobanking LIMS Software Product Portfolio
- 12.5.5 CloudLIMS Recent Developments
- 12.6 LabCollector
- 12.6.1 LabCollector Company Information
- 12.6.2 LabCollector Business Overview
- 12.6.3 LabCollector Revenue in Biobanking LIMS Software Business (2021-2026)
- 12.6.4 LabCollector Biobanking LIMS Software Product Portfolio
- 12.6.5 LabCollector Recent Developments
- 12.7 OpenSpecimen
- 12.7.1 OpenSpecimen Company Information
- 12.7.2 OpenSpecimen Business Overview
- 12.7.3 OpenSpecimen Revenue in Biobanking LIMS Software Business (2021-2026)
- 12.7.4 OpenSpecimen Biobanking LIMS Software Product Portfolio
- 12.7.5 OpenSpecimen Recent Developments
- 12.8 BSI Systems
- 12.8.1 BSI Systems Company Information
- 12.8.2 BSI Systems Business Overview
- 12.8.3 BSI Systems Revenue in Biobanking LIMS Software Business (2021-2026)
- 12.8.4 BSI Systems Biobanking LIMS Software Product Portfolio
- 12.8.5 BSI Systems Recent Developments
- 12.9 TDBioBank
- 12.9.1 TDBioBank Company Information
- 12.9.2 TDBioBank Business Overview
- 12.9.3 TDBioBank Revenue in Biobanking LIMS Software Business (2021-2026)
- 12.9.4 TDBioBank Biobanking LIMS Software Product Portfolio
- 12.9.5 TDBioBank Recent Developments
- 12.10 Autoscribe
- 12.10.1 Autoscribe Company Information
- 12.10.2 Autoscribe Business Overview
- 12.10.3 Autoscribe Revenue in Biobanking LIMS Software Business (2021-2026)
- 12.10.4 Autoscribe Biobanking LIMS Software Product Portfolio
- 12.10.5 Autoscribe Recent Developments
- 12.11 LabVantage
- 12.11.1 LabVantage Company Information
- 12.11.2 LabVantage Business Overview
- 12.11.3 LabVantage Revenue in Biobanking LIMS Software Business (2021-2026)
- 12.11.4 LabVantage Biobanking LIMS Software Product Portfolio
- 12.11.5 LabVantage Recent Developments
- 12.12 Thermo Fisher Scientific
- 12.12.1 Thermo Fisher Scientific Company Information
- 12.12.2 Thermo Fisher Scientific Business Overview
- 12.12.3 Thermo Fisher Scientific Revenue in Biobanking LIMS Software Business (2021-2026)
- 12.12.4 Thermo Fisher Scientific Biobanking LIMS Software Product Portfolio
- 12.12.5 Thermo Fisher Scientific Recent Developments
- 12.13 Ocimum Biosolutions
- 12.13.1 Ocimum Biosolutions Company Information
- 12.13.2 Ocimum Biosolutions Business Overview
- 12.13.3 Ocimum Biosolutions Revenue in Biobanking LIMS Software Business (2021-2026)
- 12.13.4 Ocimum Biosolutions Biobanking LIMS Software Product Portfolio
- 12.13.5 Ocimum Biosolutions Recent Developments
- 12.14 LabKey
- 12.14.1 LabKey Company Information
- 12.14.2 LabKey Business Overview
- 12.14.3 LabKey Revenue in Biobanking LIMS Software Business (2021-2026)
- 12.14.4 LabKey Biobanking LIMS Software Product Portfolio
- 12.14.5 LabKey Recent Developments
- 12.15 Azenta US
- 12.15.1 Azenta US Company Information
- 12.15.2 Azenta US Business Overview
- 12.15.3 Azenta US Revenue in Biobanking LIMS Software Business (2021-2026)
- 12.15.4 Azenta US Biobanking LIMS Software Product Portfolio
- 12.15.5 Azenta US Recent Developments
- 12.16 Modul-Bio
- 12.16.1 Modul-Bio Company Information
- 12.16.2 Modul-Bio Business Overview
- 12.16.3 Modul-Bio Revenue in Biobanking LIMS Software Business (2021-2026)
- 12.16.4 Modul-Bio Biobanking LIMS Software Product Portfolio
- 12.16.5 Modul-Bio Recent Developments
- 12.17 LIMSABC
- 12.17.1 LIMSABC Company Information
- 12.17.2 LIMSABC Business Overview
- 12.17.3 LIMSABC Revenue in Biobanking LIMS Software Business (2021-2026)
- 12.17.4 LIMSABC Biobanking LIMS Software Product Portfolio
- 12.17.5 LIMSABC Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst